American Dental Association following a small but growing number of reports linking bisphosphonate drugs like Fosamax, Boniva, and Actonel to incidences of osteonecrosis of the jaw (dead bone tissue), believes that dentists should discuss ONJ risks with dental patients who are taking Fosamax, Boniva, and Actonel when performing tooth extraction or doing implants.

A failure to do so could constitute Dental Malpractice. Dentists and their patients should carefully consider these procedures and discuss alternative dental therapies.